title: Sideroblastic anemia following treatment of chronic myeloid leukemia with busulfan.
authors.forename: S M
authors.initials: SM
authors.lastname: Magalhães
authors.forename: F B
authors.initials: FB
authors.lastname: Duarte
authors.forename: S C
authors.initials: SC
authors.lastname: Ribeiro
authors.forename: C L
authors.initials: CL
authors.lastname: Borovik
authors.forename: I
authors.initials: I
authors.lastname: Lorand-Metze
mesh_terms: D000368:Aged; D000756:Anemia, Sideroblastic / Q000139:chemically induced*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002066:Busulfan / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D002066:Busulfan